This inventor holds 2 USPTO granted patents and 1 EPO patent. Top assignee: Merck Sharp & Dohme LLC. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Elisabeth Hennessy: Innovator in Pharmaceutical Research
Introduction
Elisabeth Hennessy is a prominent inventor based in Boston, MA. She has made significant contributions to the field of pharmaceutical research, particularly in the development of innovative compounds. Her work has led to the creation of a patent that addresses critical medical challenges.
Latest Patents
Elisabeth holds a patent for "Spirocyclic-Substituted 6,7-Dihydro-Pyrano[2,3-d]Pyrimidine Inhibitors of KRAS G12C Mutant." This invention represents a breakthrough in targeting specific mutations associated with cancer, showcasing her expertise and dedication to advancing medical science.
Career Highlights
Elisabeth is currently employed at Merck Sharp & Dohme LLC, a leading global healthcare company. Her role involves extensive research and development, where she collaborates with other experts in the field to bring innovative solutions to market.
Collaborations
One of her notable collaborators is Andrew J Hoover, with whom she has worked closely on various projects. Their partnership exemplifies the importance of teamwork in driving innovation within the pharmaceutical industry.
Conclusion
Elisabeth Hennessy's contributions to pharmaceutical research and her innovative patent highlight her role as a key figure in the industry. Her work continues to inspire advancements in medical treatments and therapies.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile